Strides Pharma Science Shares Surge 4% on Strong Earnings
By Rediff Money Desk, New Delhi Jul 30, 2024 12:12
Strides Pharma Science shares jumped 4% on Tuesday after the company reported a strong profit after tax of Rs 84 crore for the June quarter. The stock hit a 52-week high.
New Delhi, Jul 30 (PTI) Shares of Strides Pharma Science rose 4 per cent in the morning trade on Tuesday after the company said its profit after tax from continuing operations stood at Rs 84 crore for the June quarter.
The stock of the company climbed 4.02 per cent to trade at Rs 1,071.60 apiece on the National Stock Exchange (NSE).
On the BSE, the scrip of Strides Pharma Science jumped 3.54 per cent to trade at Rs 1,070.35 per piece.
In the intra-day session, the pharmaceutical company's stock advanced to hit its 52-week of Rs 1,123 and 1,120.30 apiece on the NSE and the BSE, respectively.
The 30-share BSE benchmark bounced 365.99 points, or 0.45 per cent, to 81,721.83 while NSE Nifty rose 112.65 points to trade at 24,948.75 on Tuesday.
Strides Pharma Science on Monday said its profit after tax from continuing operations stood at Rs 84 crore for the first quarter of the current fiscal.
The drug firm had reported a loss of Rs 29.5 crore in the year-ago period, the company said in a regulatory filing.
Its revenue stood at Rs 1,087 crore in the period under review, compared to Rs 932 crore a year ago, it added.
The stock of the company climbed 4.02 per cent to trade at Rs 1,071.60 apiece on the National Stock Exchange (NSE).
On the BSE, the scrip of Strides Pharma Science jumped 3.54 per cent to trade at Rs 1,070.35 per piece.
In the intra-day session, the pharmaceutical company's stock advanced to hit its 52-week of Rs 1,123 and 1,120.30 apiece on the NSE and the BSE, respectively.
The 30-share BSE benchmark bounced 365.99 points, or 0.45 per cent, to 81,721.83 while NSE Nifty rose 112.65 points to trade at 24,948.75 on Tuesday.
Strides Pharma Science on Monday said its profit after tax from continuing operations stood at Rs 84 crore for the first quarter of the current fiscal.
The drug firm had reported a loss of Rs 29.5 crore in the year-ago period, the company said in a regulatory filing.
Its revenue stood at Rs 1,087 crore in the period under review, compared to Rs 932 crore a year ago, it added.
Source: PTI
DISCLAIMER - This article is from a syndicated feed. The original source is responsible for accuracy, views & content ownership. Views expressed may not reflect those of rediff.com India Limited.
You May Like To Read
TODAY'S MOST TRADED COMPANIES
- Company Name
- Price
- Volume
- Srestha Finvest
- 0.89 ( 0.00)
- 69758135
- Standard Capital
- 1.26 ( -16.00)
- 55792425
- GTL Infrastructure
- 2.37 (+ 4.87)
- 50169700
- Vodafone Idea L
- 9.18 ( -1.50)
- 27130818
- Jaiprakash Power Ven
- 22.33 ( -2.45)
- 21183721
MORE NEWS
Mexico to Build Own Electric Car After Tesla Snub
Mexico's president vows to create an affordable electric car after Tesla scrapped plans...
Amul Ice Cream Tampering Video Resurfaces:...
GCMMF has denied allegations of tampering with Amul ice cream after an old video...
Indo-European Relations: Convergence of Values...
FEBI President Remi Maillard highlights the strong Indo-European relationship driven by...